In a setback for Merck (MRK), a court in London ruled that the big drug maker breached a decades-old agreement with Merck KGgA — an entirely different pharmaceutical company — and infringed on a trademark by using the name “Merck” in the United Kingdom.
The ruling by the High Court of Justice, which follows an appeal of a similar decision four years ago, is the latest twist in a convoluted but heated battle between the two drug makers over their corporate nomenclature.
What is this and why are both companies making this such a big deal and acrimonious interactions? IMO both companies should be forbidden to use the wordquired Merck alone for any public documents for any purposes and instead required to use Merck KGga and Merck Sharp & dohme. Each time and everybtime!
Comments are closed.